Drugs & Side Effects |

COX-2 / Arthritis News

New Arthritis Treatment Approved in Canada

RSS News Feeds
Drugs & Pharmacuticals
COX-2 / Arthritis
Bextra
Stevens Johnson Syndrome
Stroke
Heart Attacks
Heart Valve Disease
Arthritis Care
Vioxx
 All RSS Feeds

At a glance:

Health Canada has approved a new medication, rituximab (Rituxan) for the treatment of rheumatoid arthritis, to be used in combination with Methotrexate for patients resistant to other therapies. 
 
Rituxan selectively binds to "B" cells which are thought to play a large role in the disease. 
 
Rituxan has already been used to treat Non-Hodgkins lymphoma, and is generally well-tolerated.

Health Canada Approves Unique Rheumatoid Arthritis Treatment

Canada NewsWire - 6/20/2006 6:36 AM

MISSISSAUGA, ON, June 20 /CNW/ - Hoffmann-La Roche Limited announced
 
today that Health Canada has approved Rituxan(R) (rituximab) in combination
 
with methotrexate to reduce signs and symptoms in adult patients with
 
moderately to severely active rheumatoid arthritis who have had an inadequate
 
response or intolerance to one or more tumour necrosis factor (TNF) inhibitor
 
therapies.
 
Rheumatoid arthritis affects 300,000 individuals or every one in 100
 
Canadians(1). Rituxan is the first in a new class of biologic therapies that
 
selectively targets B-cells which are thought to play a key role in the
 
development and progression of the disease
 
· Read The Full COX-2 / Arthritis Article From Canada NewsWire -->

· Read All COX-2 Inhibitors & Arthritis Medications News Stories -->

Comments On COX-2 / Arthritis News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: